Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0YP4F
|
|||
Former ID |
DNC009744
|
|||
Drug Name |
N1-hydroxy-N8-(4-phenylthiazol-2-yl)octanediamide
|
|||
Synonyms |
CHEMBL511212; N1-hydroxy-N8-(4-phenylthiazol-2-yl)octanediamide; BDBM50258645
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H21N3O3S
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)CCCCCCC(=O)NO
|
|||
InChI |
1S/C17H21N3O3S/c21-15(10-6-1-2-7-11-16(22)20-23)19-17-18-14(12-24-17)13-8-4-3-5-9-13/h3-5,8-9,12,23H,1-2,6-7,10-11H2,(H,20,22)(H,18,19,21)
|
|||
InChIKey |
BDTAPZUZFJRPNM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: effects on HDAC biology and antiproliferative activity. Bioorg Med Chem Lett. 2009 Jun 1;19(11):3023-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.